CStone Pharma raises $260 mln
CStone Pharmaceuticals said May 8 that it raised $260 million in financing led by GIC Private Ltd. Participating in the round were Sequoia China, Yunfeng Capital, 6 Dimensions Capital, CITIC PE, Taikang Insurance Group, ARCH Venture Partners, Hillhouse Capital, King Star Capital, 3W Partners, AVICT, and Terra Mafnum Capital Partners. Existing investors also taking part include Oriza Seed Venture Capital , Boyu Capital, and WuXi Healthcare Ventures. CStone, of Suzhou, China, is a biopharmaceutical company focused on drugs and combination therapies in immuno-oncology.
9 May 2018•4 mins read
